Evidence map›Paper›PMID 32618072›Full record

ArticleReviews in medical virology2020

Covid-19: Time for a paradigm change.

Franco M Buonaguro, Paolo A Ascierto, Gene D Morse, Luigi Buonaguro, Igor Puzanov, Maria Lina Tornesello, Christian Bréchot, Robert C Gallo

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Reviews in medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Highly pathogenic coronaviruses and the kidney.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  7. Review
  8. Article
  9. Omicron - The new SARS-CoV-2 challenge?Reviews in medical virology · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Observational
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Franco M BuonaguroIstituto Nazionale Tumori-IRCCS "Fondazione G. Pascale", Naples, Italy.
Paolo A AsciertoIstituto Nazionale Tumori-IRCCS "Fondazione G. Pascale", Naples, Italy.
Gene D MorseCenter for Integrated Global Biomedical Sciences, University at Buffalo, The State University of New York, USA.
Luigi BuonaguroIstituto Nazionale Tumori-IRCCS "Fondazione G. Pascale", Naples, Italy.
Igor PuzanovRoswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Maria Lina TorneselloIstituto Nazionale Tumori-IRCCS "Fondazione G. Pascale", Naples, Italy.
Christian BréchotGlobal Virus Network, University of South Florida, Tampa, Florida, USA.
Robert C GalloInstitute of Human Virology, Baltimore, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Lung InjuryAnaphylaxisAntibodies, MonoclonalAntiviral AgentsBetacoronavirusComplement C5aCoronavirus InfectionsCOVID-19Cytokine Release SyndromeCytokinesDisease ProgressionGene Expression RegulationHost-Pathogen InteractionsHumansLymphocytesMolecular Targeted TherapyAntibodies, MonoclonalAntiviral AgentsComplement C5aCytokines

Identifiers

PMID32618072
PMCPMC7361272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.